Back

Integrating Histologic Descriptors into the Ninth Edition TNM Staging Improves Prognostic Stratification of Lung Adenocarcinoma

Abolfathi, H.; Maranda-Robitaille, M.; Lamaze, F. C.; Kordahi, M.; Armero, V. S.; Orain, M.; Fiset, P. O.; Joubert, D.; Desmeules, P.; Gagne, A.; Yatabe, Y.; Bosse, Y.; Joubert, P.

2026-02-18 pathology
10.64898/2026.02.17.26346481 medRxiv
Show abstract

BackgroundHistologic descriptors such as lymphovascular invasion (LVI), visceral pleural invasion (VPI), spread through air spaces (STAS), and grading system have each been associated with adverse outcomes in lung adenocarcinoma (LUAD). However, with the exception of VPI, these features are not formally incorporated into the TNM staging system. We evaluated the prognostic value and incremental contribution of these histologic descriptors within the framework of the 9th edition TNM staging system. MethodsIn total, 1,745 individuals diagnosed with stage I-III invasive non-mucinous lung adenocarcinoma (NM-LUAD) were included in this study, comprising 1139 French-Canadian patients who underwent surgical resection at IUCPQ-Universite Laval (discovery cohort) and 606 patients from the National Cancer Center Hospital in Tokyo, Japan (validation cohort). The objective of this study was to assess the prognostic contribution of histologic descriptors, including STAS, and LVI, as complements to conventional 9th edition TNM staging. ResultsGrade 3 tumors, LVI, and STAS were identified in 880 (50.4%), 809 (46.4%), and 775 (44.4%) of 1745 cases, respectively. Histologic grade and LVI demonstrated the strongest associations, particularly in early-stage disease, while STAS exhibited a stage-dependent effect, being more impactful in stages II-III. VPI showed less consistent prognostic value. Incorporating these histologic descriptors into TNM staging improved prognostic model performance, with the largest gains driven by histologic grade and LVI, while STAS provided additional, complementary prognostic refinement. ConclusionThese findings demonstrate that key histologic descriptors--including grading system, LVI, and STAS--represent robust and reproducible prognostic parameters. Importantly, these descriptors provide complementary, stage-dependent information that may enhance risk stratification and inform refinement of future TNM staging frameworks, including the forthcoming 10th edition.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 10%
18.2%
2
Modern Pathology
21 papers in training set
Top 0.1%
14.3%
3
Scientific Reports
3102 papers in training set
Top 28%
4.3%
4
JNCI Cancer Spectrum
10 papers in training set
Top 0.1%
4.3%
5
American Journal of Respiratory and Critical Care Medicine
39 papers in training set
Top 0.3%
3.6%
6
The Lancet Digital Health
25 papers in training set
Top 0.1%
3.6%
7
The American Journal of Pathology
31 papers in training set
Top 0.1%
3.2%
50% of probability mass above
8
International Journal of Cancer
42 papers in training set
Top 0.3%
3.2%
9
Journal of Clinical Pathology
12 papers in training set
Top 0.1%
2.6%
10
eBioMedicine
130 papers in training set
Top 0.8%
2.1%
11
JAMA Network Open
127 papers in training set
Top 2%
2.1%
12
Frontiers in Immunology
586 papers in training set
Top 3%
2.1%
13
Annals of Translational Medicine
17 papers in training set
Top 0.5%
1.9%
14
European Respiratory Journal
54 papers in training set
Top 0.8%
1.9%
15
JNCI: Journal of the National Cancer Institute
16 papers in training set
Top 0.3%
1.7%
16
Cancers
200 papers in training set
Top 3%
1.7%
17
Molecular Oncology
50 papers in training set
Top 0.4%
1.7%
18
British Journal of Cancer
42 papers in training set
Top 1.0%
1.5%
19
Gastroenterology
40 papers in training set
Top 1%
1.2%
20
Nature Communications
4913 papers in training set
Top 56%
1.2%
21
The Journal of Pathology
22 papers in training set
Top 0.3%
0.9%
22
Computers in Biology and Medicine
120 papers in training set
Top 4%
0.9%
23
Cureus
67 papers in training set
Top 5%
0.8%
24
Journal for ImmunoTherapy of Cancer
64 papers in training set
Top 1%
0.7%
25
American Journal of Respiratory Cell and Molecular Biology
38 papers in training set
Top 0.7%
0.7%
26
Frontiers in Public Health
140 papers in training set
Top 8%
0.7%
27
Diagnostics
48 papers in training set
Top 2%
0.7%
28
Signal Transduction and Targeted Therapy
29 papers in training set
Top 1%
0.7%
29
Clinical Infectious Diseases
231 papers in training set
Top 5%
0.7%
30
European Radiology
14 papers in training set
Top 0.7%
0.7%